Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jodi V Mones"'
Autor:
Maria M. Rubinstein, Cheryl Goss, Scott T. Avecilla, Gregory P. Dubé, Gregory J. Riely, Jodi V. Mones
Publikováno v:
Clinical Case Reports, Vol 8, Iss 2, Pp 289-292 (2020)
Abstract Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure®, Waltham
Externí odkaz:
https://doaj.org/article/c3cd86fc5e4947e7bc74104957d89e2a
Autor:
Cy R. Wilkins, Jocelyn Ortiz, Leah J. Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Chemotherapy‐induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity. There is no approved therapy for CIT. In our recent phase II randomized s
Externí odkaz:
https://doaj.org/article/55728aab962a421eb55e38afe5a64bc0
Autor:
Jodi V. Mones, Michael B. Streiff, Alok A. Khorana, Gemma A. Bendheim, C. V. Damaraju, Peter Wildgoose, Paul Burton, Hanno Riess, Gerald A. Soff
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract Background Prophylactic anticoagulation with rivaroxaban significantly reduced the risk of cancer‐associated thrombosis during the intervention period in the CASSINI trial. Direct oral anticoagulants may increase the risk of gastrointestin
Externí odkaz:
https://doaj.org/article/01708f1762434189891ef90745374b08
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Leukocytosis is a common feature of malignancies. While controversial, there appears to be an association between the degree of tumor-related leukocytosis and prognosis. In this paper, we provide evidence supporting an untapped clinical paradigm link
Externí odkaz:
https://doaj.org/article/ba5fc6a663c0496ba5de951125cda2da
Publikováno v:
American Journal of Hematology. 98:830-832
Autor:
Cy R. Wilkins, Jocelyn Ortiz, Leah J. Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(3)
Chemotherapy-induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity. There is no approved therapy for CIT. In our recent phase II randomized study, romiplostim led
Autor:
Gregory J. Riely, Cheryl Goss, Scott T. Avecilla, Maria M. Rubinstein, Jodi V. Mones, Gregory P. Dubé
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 2, Pp 289-292 (2020)
Clinical Case Reports, Vol 8, Iss 2, Pp 289-292 (2020)
Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure®, Waltham, MA) for
Autor:
Jeanette Batista, Michael E Singer, Krishna Juluru, Gerald A. Soff, Jodi V. Mones, Sean M. Devlin, Cy Wilkins, Jonathan Wills, Simon Mantha, Yimei Miao, Eva Haegler-Laube, Debra M. Sarasohn
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 349-356 (2019)
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 349-356 (2019)
Background Low‐molecular‐weight heparin has been the preferred treatment of cancer‐associated thrombosis (CAT); however, emerging data support the use of direct oral anticoagulants (DOACs). Objectives The Memorial Sloan Kettering Cancer Center
Autor:
Gemma Bendheim, Michael B. Streiff, Jodi V. Mones, Gerald A. Soff, Hanno Riess, Paul Burton, Alok A. Khorana, C.V. Damaraju, Peter Wildgoose
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Background Prophylactic anticoagulation with rivaroxaban significantly reduced the risk of cancer-associated thrombosis during the intervention period in the CASSINI trial. Direct oral anticoagulants may increase the risk of gastrointestinal (GI) tra
Autor:
Mirko Farina, Young C. Park, Ross L. Levine, Wungki Park, Gerald A. Soff, Simon Mantha, Jianjiong Gao, Sean M. Devlin, Ahmet Zehir, Daniel Kelly, Neil M. Iyengar, Andrew Dunbar, Jonathan Wills, Alok A. Khorana, Kelly L. Bolton, Francisco Sanchez-Vega, Jodi V. Mones, Sirish Kishore, Krishna Juluru, Keith B. Cordner
Publikováno v:
Blood. 137(15)
Cancer-associated venous thromboembolism (CAT) is a well-described complication of cancer and a leading cause of death in cancer patients. The purpose of this study was to assess potential associations of molecular signatures with CAT, including tumo